« Back
Home /
Anbenitamab Biosimilar（Anti-ERBB2 / HER2 / CD340 Reference Antibody）

Anbenitamab Biosimilar（Anti-ERBB2 / HER2 / CD340 Reference Antibody）

Item no.	DCC-A1004-100mg
Manufacturer	DCChemicals
CASRN	2367012-88-0
Amount	100 mg
Category	In Vivo Flow Cytometry
Applications	FC, IV
Specific against	other
Available
Manufacturer - Applications	Anbenitamab (KN-026) is a bispecific antibody simultaneously targeting the extracellular domains II and IV of the human HER2. Anbenitamab blocks both ligand-dependent and ligand-independent HER2 signaling pathway. The IgG1 Fc fragment of Anbenitamab binds FcRγIIIa mediates potent antibody dependent cell-mediated cytotoxicity (ADCC) and inhibits tumor cell proliferation. Anbenitamab has the potential for HER2-positive metastatic breast cancer (MBC) research.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 12/11/2025

Compare

Add to wishlist

Get an offer

Request delivery time